For dementia with Lewy bodies (DLB), biomarkers may include the RNA expression levels in small EVs circulating in plasma or altered protein levels in plasma EVs, such as gelsolin and butyrylcholinesterase [111,112,113]. The gene discussed is BCHE; the disease is Lewy body dementia.